Dervla T Isaac

Dervla T Isaac, Ph.D., currently serves as the Associate Director of Immunology at Passkey Therapeutics, a role commenced in November 2024. Prior to this position, Dervla held the title of Associate Director of Immunology (Discovery Biology) at Ribon Therapeutics from May 2022 to October 2023, where Dervla led an Immunology group focused on supporting clinical and pre-clinical programs, including a notable PROTAC program. Dervla has also contributed to Pyxis Oncology as a Principal Scientist and Senior Scientist, managing antibody discovery campaigns, and led early discovery immune-oncology platform efforts at Kintai Therapeutics as a Senior Scientist. Dervla's academic background includes a Ph.D. in Biochemistry and Molecular Biology from the University of California, San Francisco, and a cum laude Bachelor’s Degree in Biochemical Sciences from Harvard University.